Detalles de la búsqueda
1.
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.
Lancet;
403(10422): 160-170, 2024 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104575
2.
Trial of SAGE-217 in Patients with Major Depressive Disorder.
N Engl J Med;
381(10): 903-911, 2019 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31483961
3.
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial.
JAMA Psychiatry;
2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38691387
4.
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.
Crit Care Med;
41(9): 2069-79, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23979365
5.
Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study.
J Neurol Sci;
421: 117277, 2021 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387701
6.
SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies.
Clin Pharmacokinet;
59(1): 111-120, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31338688
7.
Dysregulation of inflammatory and hemostatic markers in sepsis and suspected disseminated intravascular coagulation.
Clin Appl Thromb Hemost;
21(2): 120-7, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24254894
8.
Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin.
Clin Appl Thromb Hemost;
20(2): 129-35, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23804232
Resultados
1 -
8
de 8
1
Próxima >
>>